Allergy and Asthma Proceedings

The Asthma Risk Grid: Clinical Interpretation of Symptom Perception
pp. 1-6(6)
Authors: Klein, Robert B.; Walders, Natalie; McQuaid, Elizabeth L.; Adams, Sue; Yaros, Diane; Fritz, Gregory K.

Risk Factors in Allergy/Asthma
pp. 7-10(4)
Author: Kaiser, Harold B.

Therapeutic Measures for Prevention of Allergic Rhinitis/Asthma Development
pp. 11-15(5)
Author: Stanaland, Brett E.

Interleukin-17 and the Interleukin-17 Family Member Network
pp. 17-21(5)
Authors: Huang, Shu-Hai; Frydas, Stavros; Kempuraj, Duraisamy; Barbacane, Renato C.; Grilli, Alfredo; Boucher, William; Letourneau, Richard; Madhappan, Bhuvaneshwari; Papadopoulou, Nikoletta; Verna, Nicola; De Lutiis, Maria Anna; Iezzi, Teresa; Riccioni, Graziano; Theoharides, Theoharis C.; Conti, Pio

Perioperative Anaphylaxis to Cefazolin
pp. 23-26(4)
Authors: Lee, Chyh-Woei; Castells, Mariana C.

The Biology of the Mast Cell
pp. 27-30(4)
Author: Boyce, Joshua A.

Anaphylaxis: Clinical Aspects
pp. 31-32(2)
Author: Sheffer, Albert L.

Mastocytosis: Classification, Diagnosis, and Clinical Presentation
pp. 33-36(4)
Author: Castells, Mariana C.

Leukotriene Generation and Clinical Implications
pp. 37-42(6)
Author: Arm, Jonathan P.

Obstructive Sleep Apnea, Nasal Congestion, and Snoring: Their Systemic Effects and Impact on Quality of Life
pp. 43-51(9)
Authors: Boyd, Edwyn L.; Philpot, Edward E.

Triamcinolone Acetonide and Fluticasone Propionate Aqueous Nasal Sprays Significantly Improve Nasal Airflow in Patients with Seasonal Allergic Rhinitis
pp. 53-58(6)
Authors: Meltzer, Eli O.; Gallet, Carol L.; Jalowayski, Alfredo A.; Garcia, Jorge; Diener, Phyllis; Liao, Yuning; Georges, George

Randomized Double-Blind Comparison of Cetirizine and Fexofenadine after Pollen Challenge in the Environmental Exposure Unit: Duration of Effect in Subjects with Seasonal Allergic Rhinitis
pp. 59-68(10)
Authors: Day, James H.; Briscoe, Maureen P.; Rafeiro, Elizabeth; Hewlett, Dial; Chapman, Douglass; Kramer, Benjamin

Preclinical and Clinical Antiallergic Effect of Olopatadine 0.2% Solution 24 Hours after Topical Ocular Administration
pp. 69-75(7)
Authors: Vogelson, Cullen T.; Abelson, Mark B.; Pasquine, Terri; Stephens, Donna M.; Gamache, Daniel A.; Gross, Robert D.; Robertson, Stella M.; Yanni, John M.

Minutes of Regional, State, and Local (RSL) Allergy Societies
pp. 77-78(2)